|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|
| Operating activities | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operations: | ||
| Depreciation and amortization | ||
| Amortization of debt issuance costs | ||
| Share-based compensation | ||
| CoyCo 2 share-based compensation | ||
| Gain on sale of Emergency Medical Services business | ||
| Loss/(gain) on disposal and right-of-use asset write-downs | ||
| Provision for credit losses | ||
| Deferred income taxes | ||
| Non-cash lease expense | ||
| Other | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable and related party accounts receivable | ||
| Contract assets | ||
| Prepaid expenses and other assets | ||
| Accounts payable | ||
| Accrued compensation and benefits | ||
| Lease liabilities | ||
| Operating lease liabilities | ||
| Other liabilities | ||
| Customer liabilities and customer liabilities - related party | ||
| Net cash provided by (used in) operating activities | ||
| Investing activities | ||
| Purchases of property, equipment, and software | ||
| Payment for business acquisitions, net of cash acquired | ||
| Proceeds from sale of Emergency Medical Services business, net of cash disposed | ||
| Other | ||
| Net cash used in investing activities | ||
| Financing activities | ||
| Issuance of senior secured debt, net of discount and issuance costs and borrowings on revolver | ||
| Senior Term Loan | ||
| Senior Revolver | ||
| Payment of debt issuance costs | ||
| Repayment of senior secured debt and revolver | ||
| Senior Term Loan | ||
| Senior Revolver | ||
| Payment of contingent consideration liability | ||
| Deferred payment related to acquisition of RevWorks | ||
| Inducement of preferred stock conversion | ||
| Payment of equity issuance costs | ||
| Exercise of vested stock options | ||
| Purchase of treasury stock | ||
| Shares withheld for taxes | ||
| Other | ||
| Net cash (used in) provided by financing activities | ||
| Effect of exchange rate changes in cash | ||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | ||
| Cash, cash equivalents, and restricted cash at beginning of period | ||
| Cash, cash equivalents, and restricted cash at end of period | ||
| Supplemental disclosures of cash flow information | ||
| Accrued dividends payable to preferred stockholders | ||
| Property, equipment and software purchases not paid | ||
| Assets obtained in exchange for common stock | ||
| Interest paid | ||
| Income taxes paid | ||
| Income taxes refunded |
Loading...